🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 16 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/02/2008 8,58 8,88 8,16 8,76 +5,04% 8,39% 64.583
15/02/2008 8,22 8,58 7,80 8,34 +2,96% 9,49% 51.183
14/02/2008 8,76 9,18 7,86 8,10 -8,78% 15,07% 94.583
13/02/2008 8,46 8,88 8,28 8,88 +4,96% 7,09% 75.817
12/02/2008 7,80 8,46 7,74 8,46 +8,46% 9,23% 110.933
11/02/2008 6,48 7,98 6,42 7,80 +19,27% 24,07% 166.650
08/02/2008 6,72 6,84 6,36 6,54 -0,91% 7,14% 70.617
07/02/2008 6,54 7,02 6,36 6,60 +2,80% 10,09% 102.100
06/02/2008 7,02 7,20 6,42 6,42 -9,32% 11,11% 123.067
05/02/2008 7,56 7,68 7,02 7,08 -7,81% 8,73% 99.083
04/02/2008 7,86 7,86 7,44 7,68 +0,00% 5,34% 86.317
01/02/2008 7,50 7,74 7,32 7,68 +3,23% 5,60% 35.383
31/01/2008 7,50 7,50 7,02 7,44 -1,59% 6,40% 52.783
30/01/2008 7,74 7,74 7,38 7,56 -2,33% 4,65% 30.367
29/01/2008 7,26 7,74 7,02 7,74 +6,61% 9,92% 78.967
28/01/2008 7,50 7,50 7,02 7,26 -0,82% 6,40% 57.700
25/01/2008 7,56 7,68 6,96 7,32 -3,17% 9,52% 78.267
24/01/2008 7,98 7,98 7,50 7,56 -2,33% 6,02% 29.917
23/01/2008 7,80 8,04 7,44 7,74 -5,15% 7,69% 73.067
22/01/2008 7,56 8,16 6,00 8,16 -0,73% 28,57% 68.700
18/01/2008 8,34 8,64 7,98 8,22 +1,48% 7,91% 85.350
17/01/2008 8,58 8,88 8,10 8,10 -6,90% 9,09% 68.200
16/01/2008 8,40 8,88 8,22 8,70 +1,40% 7,86% 50.600
15/01/2008 8,64 8,82 8,10 8,58 -1,38% 8,33% 47.467
14/01/2008 8,88 9,18 8,58 8,70 -2,03% 6,76% 56.167
11/01/2008 8,94 9,00 8,64 8,88 -1,99% 4,03% 45.233
10/01/2008 8,64 9,12 8,22 9,06 +6,34% 10,42% 78.217
09/01/2008 8,58 8,70 8,28 8,52 +1,43% 4,90% 52.850
08/01/2008 7,86 8,88 7,86 8,40 +3,70% 12,98% 95.933
07/01/2008 8,46 8,70 7,98 8,10 -4,93% 8,51% 69.267